Discover
BIIB
Biogen Inc.
209.74
1 x 201.87
1 x 223.37
bid
ask
-
6.32
2.93%
1 @ 04:00 AM
209.74 +0.00 (0.00%)
| Ytd | 19.18% | |
| 1y | 61.25% |
209.67
day range
215.76
121.05
52 week range
219.72
| Open | 215.25 | Prev Close | 216.06 | Low | 209.67 | High | 215.76 | Mkt Cap | 30.97B |
| Vol | 1.10M | Avg Vol | 1.21M | EPS | 9.29 | P/E | 22.58 | Forward P/E | 12.62 |
| Beta | 0.18 | Short Ratio | 5.16 | Inst. Own | 96.26% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-29 | 50-d Avg | 195.16 | 200-d Avg | 177.27 | 1yr Est | 220.28 |
| Income Statement | |||
| Total Revenue | 2.48B | ||
| Revenues (USD) | 2.48B | ||
| Cost of Revenue | 661.00M | ||
| Gross Profit | 1.82B | ||
| Operating Expenses | 1.44B | ||
| Research and Development Expense | 539.00M | ||
| Selling, General and Administrative Expense | 607.30M | ||
| Operating Income | 377.70M | ||
| Income Tax Expense | 58.20M | ||
| Net Income | 319.50M | ||
| Net Income Common Stock | 319.50M | ||
| Net Income Common Stock (USD) | 319.50M | ||
| Consolidated Income | 319.50M | ||
| Earnings per Basic Share | 2.17 | ||
| Earnings per Basic Share (USD) | 2.17 | ||
| Earnings per Diluted Share | 2.15 | ||
| Earning Before Interest & Taxes (EBIT) | 377.70M | ||
| Earning Before Interest & Taxes (USD) | 377.70M | ||
| Weighted Average Shares | 147.20M | ||
| Weighted Average Shares Diluted | 148.40M | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.38B | ||
| Cash and Equivalents (USD) | 3.38B | ||
| Investments | 2.14B | ||
| Investments Current | 900.00M | ||
| Investments Non-Current | 1.24B | ||
| Trade and Non-Trade Receivables | 1.79B | ||
| Current Assets | 9.19B | ||
| Property, Plant & Equipment Net | 3.27B | ||
| Total Assets | 29.48B | ||
| Total Debt | 6.56B | ||
| Current Liabilities | 3.00B | ||
| Debt Non-Current | 6.56B | ||
| Total Liabilities | 10.83B | ||
| Accumulated Retained Earnings (Deficit) | 20.87B | ||
| Accumulated Other Comprehensive Income | -140.20M | ||
| Shareholders Equity | 18.65B | ||
| Shareholders Equity (USD) | 18.65B | ||
| Assets Non-Current | 20.29B | ||
| Total Debt (USD) | 6.56B | ||
| Goodwill and Intangible Assets | 15.54B | ||
| Inventory | 1.95B | ||
| Liabilities Non-Current | 7.83B | ||
| Trade and Non-Trade Payables | 358.50M | ||
| Tax Assets | 238.20M | ||
| Tax Liabilities | 577.10M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 204.40M | ||
| Net Cash Flow from Financing | -43.80M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 392.20M | ||
| Capital Expenditure | -51.20M | ||
| Net Cash Flow from Investing | -209.50M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -123.10M | ||
| Net Cash Flow from Operations | 645.50M | ||
| Effect of Exchange Rate Changes on Cash | -18.00M | ||
| Share Based Compensation | 84.00M | ||